Viking Therapeutics (VKTX) Reports In-Line Q2 EPS
Go back to Viking Therapeutics (VKTX) Reports In-Line Q2 EPS| ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) | Delayed: 31.60 -0.38 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.98 | 52 Week High | $5.17 | |||
| Open | $31.70 | 52 Week Low | $0.94 | |||
| Day High | $32.43 | P/E | N/A | |||
| Day Low | $31.46 | EPS | $0.00 | |||
| Volume | 981,056 | |||||
